. Step 15 of 41
Clinical Stem 3
A patient with right upper lobe adenocarcinoma progressing on biomarker-directed therapy

Question 5
To optimize the specimen submitted for molecular testing, which of the following items should you discuss with your pathology and oncology colleagues prior to further interventions?
A. Size and quality of the required tumor sample

B. Specific histologic sampling for molecular analysis testing

C. Specific markers needed in this patient

D. All of the above
incorrect correct
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology